Trial Profile
Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With Attention-deficit/Hyperactivity Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2021
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 11 Aug 2018 Status changed from not yet recruiting to recruiting.
- 28 Feb 2018 New trial record